Mark T. Baker
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
- Oncology 3
- Lung Cancer Research Studies 2
-
- Fatty Acid Research and Health 1
- Co-authors
- Didier Merlin (7 shared papers)Hamed Laroui (5 shared papers)Émilie Viennois (7 shared papers)Saravanan Ayyadurai (3 shared papers)Moiz A. Charania (2 shared papers)Bo Xiao (5 shared papers)Yutao Yan (2 shared papers)Fengyuan Chen (1 shared paper)
- Journals
- Anti-Cancer Drugs (2 papers)Journal of Materials Chemistry B (1 paper)PLoS ONE (1 paper)Biomaterials (1 paper)Gastroenterology (1 paper)
- Partner nations
- United StatesChinaNew Zealand
In The Last Decade
Mark T. Baker
13 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 97
- Pharmaceutical Science 121
- Biomaterials 127
- Molecular Medicine 41
- Genetics 225
- Toxicology 27
Countries citing papers authored by Mark T. Baker
This map shows the geographic impact of Mark T. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark T. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark T. Baker more than expected).
Fields of papers citing papers by Mark T. Baker
This network shows the impact of papers produced by Mark T. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark T. Baker. The network helps show where Mark T. Baker may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark T. Baker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 277 | |
| 2 | 2014 | 185 | |
| 3 | 2013 | 155 | |
| 4 | 2015 | 144 | |
| 5 | 2015 | 92 | |
| 6 | 2002 | 56 | |
| 7 | 2014 | 50 | |
| 8 | 2001 | 47 | |
| 9 | 2013 | 29 | |
| 10 | 2014 | 21 | |
| 11 | 2019 | 18 | |
| 12 | 2018 | 7 | |
| 13 | 2002 | 1 |
About Mark T. Baker
Mark T. Baker is a scholar working on Oncology, Nutrition and Dietetics, Genetics, Virology and Molecular Biology, having authored 13 papers that have together received 1.1k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (3 papers), Lung Cancer Research Studies (2 papers), Cancer therapeutics and mechanisms (2 papers), Diet and metabolism studies (1 paper), Fatty Acid Research and Health (1 paper), RNA modifications and cancer (1 paper), Nanoparticle-Based Drug Delivery (1 paper) and RNA Interference and Gene Delivery (1 paper). The work is most often cited by research in Pharmaceutical Science (121 citations), Biomaterials (127 citations), Molecular Medicine (41 citations), Genetics (225 citations) and Toxicology (27 citations). Mark T. Baker has collaborated with scholars based in United States, China and New Zealand. Frequent co-authors include Didier Merlin, Hamed Laroui, Émilie Viennois, Saravanan Ayyadurai, Moiz A. Charania, Bo Xiao, Yutao Yan, Fengyuan Chen, Sarah A. Ingersoll and Shanthi V. Sitaraman. Their work appears in journals such as Anti-Cancer Drugs, Journal of Materials Chemistry B, PLoS ONE, Biomaterials and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.